{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:00:03Z","timestamp":1791928803549,"version":"4.3.4"},"reference-count":38,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"3","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2023,3,6]]},"DOI":"10.1167\/iovs.64.3.15","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T11:30:53Z","timestamp":1678102253000},"page":"15","source":"Crossref","is-referenced-by-count":19,"title":["Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant"],"prefix":"10.1167","volume":"64","author":[{"given":"W. Daniel","family":"Stamer","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Duke University, Durham, North Carolina, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin M.","family":"Perkumas","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University, Durham, North Carolina, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min H.","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology & Visual Sciences, University Hospitals, Case Western Reserve University, Cleveland, Ohio, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Dibas","sequence":"additional","affiliation":[{"name":"Allergan, an AbbVie company, Irvine, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Allergan, an AbbVie company, Irvine, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology & Visual Sciences, University Hospitals, Case Western Reserve University, Cleveland, Ohio, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"4","key":"bib1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.exer.2008.11.025","article-title":"Structural changes of the trabecular meshwork in different kinds of glaucoma","volume":"88","author":"Tektas","year":"2009","journal-title":"Exp Eye Res"},{"issue":"4","key":"bib2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.exer.2008.11.033","article-title":"The changing paradigm of outflow resistance generation: Towards synergistic models of the JCT and inner wall endothelium","volume":"88","author":"Overby","year":"2009","journal-title":"Exp Eye Res"},{"issue":"Suppl 1","key":"bib3","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","article-title":"Side effects associated with prostaglandin analog therapy","volume":"53","author":"Alm","year":"2008","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"bib4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ophtha.2015.09.005","article-title":"Comparative effectiveness of first-line medications for primary open-angle glaucoma: A systematic review and network meta-analysis","volume":"123","author":"Li","year":"2016","journal-title":"Ophthalmology"},{"issue":"9","key":"bib5","first-page":"728","article-title":"Comparing adherence and persistence across 6 chronic medication classes","volume":"15","author":"Yeaw","year":"2009","journal-title":"J Manag Care Pharm"},{"issue":"10","key":"bib6","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","article-title":"Patterns of glaucoma medication adherence over four years of follow-up","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajo.2016.11.020","article-title":"Bimatoprost sustained-release implants for glaucoma therapy: 6-month results from a phase I\/II clinical trial","volume":"175","author":"Lewis","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"bib8","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ophtha.2020.06.018","article-title":"Phase 3, randomized, 20-month study of bimatoprost implant in open-angle glaucoma and ocular hypertension (ARTEMIS 1)","volume":"127","author":"Medeiros","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"bib9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/jop.2018.0067","article-title":"Intracameral sustained-release bimatoprost implant delivers bimatoprost to target tissues with reduced drug exposure to off-target tissues","volume":"35","author":"Seal","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"bib10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40265-019-01248-0","article-title":"24-Month phase I\/II clinical trial of bimatoprost sustained-release implant (Bimatoprost SR) in glaucoma patients","volume":"80","author":"Craven","year":"2020","journal-title":"Drugs"},{"issue":"17","key":"bib11","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s40265-021-01624-9","article-title":"Phase 3, randomized, 20-month study of the efficacy and safety of bimatoprost implant in patients with open-angle glaucoma and ocular hypertension (ARTEMIS 2)","volume":"81","author":"Bacharach","year":"2021","journal-title":"Drugs"},{"issue":"Suppl 1","key":"bib12","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.survophthal.2008.08.010","article-title":"Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction","volume":"53","author":"Toris","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and biological attributes of matrix metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"5","key":"bib14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0014-4835(88)90043-7","article-title":"Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2 alpha","volume":"47","author":"L\u00fctjen-Drecoll","year":"1988","journal-title":"Exp Eye Res"},{"issue":"8","key":"bib15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/archopht.119.8.1165","article-title":"Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment","volume":"119","author":"Gaton","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"bib16","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1167\/iovs.02-1281","article-title":"Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide","volume":"44","author":"Richter","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"bib17","first-page":"3705","article-title":"Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells","volume":"43","author":"Anthony","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"bib18","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1167\/iovs.04-0413","article-title":"Prostaglandin FP agonists alter metalloproteinase gene expression in sclera","volume":"45","author":"Weinreb","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"bib19","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1167\/iovs.06-0036","article-title":"Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells","volume":"47","author":"Oh","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"bib20","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1167\/iovs.08-3356","article-title":"Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells","volume":"50","author":"Ooi","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12886-016-0202-8","article-title":"Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases","volume":"16","author":"Yamada","year":"2016","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"bib22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/jop.2019.0146","article-title":"Matrix metalloproteinases and glaucoma treatment","volume":"36","author":"Weinreb","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"bib23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3109\/02713689508998409","article-title":"Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion","volume":"14","author":"Stamer","year":"1995","journal-title":"Curr Eye Res"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exer.2018.03.001","article-title":"Consensus recommendations for trabecular meshwork cell isolation, characterization and culture","volume":"171","author":"Keller","year":"2018","journal-title":"Exp Eye Res"},{"issue":"9","key":"bib25","first-page":"2679","article-title":"Propagation of ciliary smooth muscle cells in vitro and effects of prostaglandin F2 alpha on calcium efflux","volume":"33","author":"Weinreb","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"bib26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1167\/iovs.05-0516","article-title":"Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost","volume":"47","author":"Oh","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"bib28","first-page":"1514","article-title":"Increased human scleral permeability with prostaglandin exposure","volume":"42","author":"Kim","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"bib29","first-page":"716","article-title":"Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost","volume":"43","author":"Weinreb","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"108019","DOI":"10.1016\/j.exer.2020.108019","article-title":"Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells","volume":"194","author":"Heo","year":"2020","journal-title":"Exp Eye Res"},{"issue":"3","key":"bib31","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1167\/iovs.02-0365","article-title":"Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome\/glaucoma and primary open-angle glaucoma","volume":"44","author":"Schlotzer-Schrehardt","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.ijg.0000145812.39224.0a","article-title":"Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma","volume":"14","author":"Maatta","year":"2005","journal-title":"J Glaucoma"},{"issue":"6","key":"bib33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1006\/exer.1994.1158","article-title":"Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2","volume":"59","author":"Tripathi","year":"1994","journal-title":"Exp Eye Res"},{"issue":"1","key":"bib34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1167\/iovs.03-0796","article-title":"Effects of TGF-beta2 in perfused human eyes","volume":"45","author":"Gottanka","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"bib35","first-page":"363","article-title":"Matrix metalloproteinase-1 localization in the normal human uveoscleral outflow pathway","volume":"40","author":"Gaton","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"bib36","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1001\/archopht.117.6.794","article-title":"Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway","volume":"117","author":"Sagara","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"bib37","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ophtha.2014.12.038","article-title":"Association between SNPs of metalloproteinases and prostaglandin F2alpha receptor genes and latanoprost response in open-angle glaucoma","volume":"122","author":"Ussa","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"bib38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/(ISSN)1097-4652","article-title":"Regulation of matrix metalloproteinase gene expression","volume":"211","author":"Yan","year":"2007","journal-title":"J Cell Physiol"},{"key":"bib27","first-page":"757","article-title":"Safety evaluation of ocular drugs","volume-title":"A Comprehensive Guide to Toxicology in Nonclinical Drug Development","author":"Ferrell Ramos","year":"2016","edition":"Second Edition"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2785420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:38Z","timestamp":1791927098000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2785420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.64.3.15","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,6]]}}}